DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q

Acta Neuropathologica
M J BelloJ A Rey

Abstract

The purpose of this research was to examine the DNA methylation profile of meningiomas. Accordingly, we examined the DNA methylation status of ten tumor-related genes (RB1, p16(INK4a), p73, MGMT, ER, DAPK, TIMP-3, p14(ARF), THBS1, and Caspase-8) in 98 meningiomas (68 grade I; 27 grade II; and 3 grade III samples) using methylation-specific PCR and sequencing. The most frequently methylated genes were THBS1 (30%), TIMP-3 (24%), p16(INK4a) (17%), MGMT (16%), p73 (15%), ER (15%), and p14(ARF) (13%), whereas methylation was relatively rare in the other genes (<10%). Methylation occurred in at least one gene in 77.5% of the cases and in three or more genes in 25.5%. Methylation was tumor specific since it was absent in the controls: two non-neoplastic meningeal samples and two non-neoplastic brain samples. The frequency of aberrant gene methylation in grade I versus grade II-III tumors showed some differences for TIMP-3, THBS1, MGMT, p16(INK4a) and p73; these differences reached statistical significance for TIMP-3: 18% in grade I versus 40% in grade II-III (P < 0.02). Our previous loss of heterozygosity studies provided the allelic constitution at 1p and 22q for 60 of the 98 meningiomas included in this report. The level of aberrant...Continue Reading

References

Apr 1, 1994·Genes, Chromosomes & Cancer·M J BelloJ A Rey
Feb 1, 1994·International Journal of Cancer. Journal International Du Cancer·A LindblomJ P Dumanski
Sep 3, 1996·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Dec 6, 1996·Science·C J Sherr
Feb 7, 1998·Proceedings of the National Academy of Sciences of the United States of America·R G WeberP Lichter
Jul 8, 1998·Proceedings of the National Academy of Sciences of the United States of America·T KamijoC J Sherr
Jul 29, 2000·Cancer Genetics and Cytogenetics·M J BelloJ A Rey
Feb 24, 2001·Laboratory Investigation; a Journal of Technical Methods and Pathology·M NakamuraH Ohgaki
Feb 24, 2001·Brain Tumor Pathology·J F CostelloW K Cavenee
Apr 17, 2001·International Journal of Cancer. Journal International Du Cancer·R BüschgesG Reifenberger
Jun 12, 2001·Journal of Neuropathology and Experimental Neurology·D X CaiA Perry
Aug 7, 2001·Journal of Neuropathology and Experimental Neurology·S M DongH K Ng
Mar 21, 2003·Cancer Genetics and Cytogenetics·Mamoru MurakamiKatsuyoshi Mineura
Jun 10, 2003·International Journal of Cancer. Journal International Du Cancer·Karen UhlmannPeter W Laird
Jun 27, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P Gonzalez-GomezJ A Rey
Jul 10, 2003·Cancer Genetics and Cytogenetics·M Eva AlonsoJuan A Rey
Jul 29, 2003·Oncology Reports·Pilar Gonzalez-GomezJuan A Rey
Jan 22, 2004·Cancer Genetics and Cytogenetics·Concha Lopez-GinesAntonio Llombart-Bosch
Jan 22, 2004·Cancer Genetics and Cytogenetics·Jesus LomasJuan A Rey
Apr 10, 2004·Journal of Neuro-oncology·M Eva AlonsoJuan A Rey
Apr 10, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Vishwa Jeet AmatyaKouki Inai

❮ Previous
Next ❯

Citations

Nov 18, 2006·Lancet Neurology·Markus J RiemenschneiderGuido Reifenberger
Feb 8, 2006·DNA and Cell Biology·Laurent SabbaghRafick-Pierre Sékaly
Apr 12, 2014·PloS One·Stefan LinslerSteffi Urbschat
May 2, 2008·Journal of Neurosurgery·Alexander SemmlerMichael Linnebank
Jan 16, 2016·Journal of Neurosurgery·Wenya Linda BiIan F Dunn
Dec 21, 2007·Brain Pathology·Gilson S BaiaAnita Lal
Mar 26, 2016·Neurosurgery Clinics of North America·Wenya Linda BiIan F Dunn
Nov 11, 2008·Cancer Genetics and Cytogenetics·Paula de RoblesJacob Easaw
May 2, 2015·Brain Tumor Pathology·Mario VenzaIsabella Venza
Oct 4, 2018·Medical Sciences : Open Access Journal·Ugo TestaElvira Pelosi
Sep 20, 2006·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·Luis LassalettaJavier Gavilan
Aug 5, 2005·Cancer·David M AshleyChristine J Hawkins
Jan 23, 2020·Journal of Pathology and Translational Medicine·Young Suk Lee, Youn Soo Lee
May 8, 2010·Journal of Neuro-oncology·Benjamin BrokinkelMartin Hasselblatt
Oct 6, 2020·Frontiers in Oncology·Lu ShenAnwen Shao
May 13, 2015·Oncotarget·Patrícia DominguesMaría Dolores Tabernero
Nov 14, 2014·Journal of Neuro-oncology·Chih-Yi HsuDonald Ming-Tak Ho
Feb 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Leila LarijaniAfshin Moradi
Nov 16, 2019·Journal of Neuro-oncology·Anne GuyotFrançois Labrousse
Jan 17, 2019·Neuro-oncology·Suganth SuppiahUNKNOWN International Consortium on Meningiomas
Aug 16, 2013·Oncology Letters·Miguel Torres-MartínJuan A Rey
Jul 25, 2021·Journal of Clinical Medicine·Philip D TatmanD Ryan Ormond
Aug 14, 2021·Scientific Reports·Pim J J DamenErnst Jan M Speel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.